Glucose (Hexokinase) Delta Test Assay
by Bd Becton Dickinson Vacutainer Systems Preanalytic 510(k)
Active
510(k) K770262
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK770262 | Date23 Feb 1977 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- CFR
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1345
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Glucose (Hexokinase) Delta Test Assay is an in vitro diagnostic device classified as a hexokinase-based glucose measurement system. It quantifies glucose levels in blood and other body fluids using enzymatic methods, enabling clinical assessment of carbohydrate metabolism disorders such as diabetes mellitus, neonatal hypoglycemia, and pancreatic islet cell carcinoma.
This assay is supplied as a reagent kit for use in clinical chemistry laboratories. It is intended for single-use applications and requires no special storage conditions beyond those specified in the accompanying instructions. The device holds an FDA 510(k) clearance under the classification of Clinical Chemistry, with a decision date of February 23, 1977, and is regulated under CFR 862.1345. No third-party review or additional regulatory markings are indicated.
Other devices from Bd Becton Dickinson Vacutainer Systems Preanalytic
See all devices from Bd Becton Dickinson Vacutainer Systems Preanalytic →
Questions
AI-generated answers, 1 Oct 2026
What is the Glucose (Hexokinase) Delta Test Assay used for?
This assay is designed for in vitro diagnostic use to quantify glucose levels in blood and other body fluids. It employs enzymatic hexokinase methods to help clinicians assess carbohydrate metabolism disorders, including diabetes mellitus, neonatal hypoglycemia, and pancreatic islet cell carcinoma. The results aid in diagnosing and monitoring these conditions by providing accurate glucose measurements.
How is the Glucose (Hexokinase) Delta Test Assay supplied, and is it single-use?
The assay is supplied as a reagent kit intended for use in clinical chemistry laboratories. It is explicitly designed for single-use applications, meaning each kit is meant to be used once before disposal. This ensures consistency and reliability in test results while minimizing the risk of contamination.
Are there any special storage requirements for this assay kit?
The kit does not require special storage conditions beyond those outlined in the accompanying instructions. Standard laboratory storage practices, such as protecting it from extreme temperatures and light, should be followed to maintain its integrity and performance. Always refer to the included documentation for precise storage guidelines.
What regulatory clearance does the Glucose (Hexokinase) Delta Test Assay hold?
This assay holds an FDA 510(k) clearance under the classification of Clinical Chemistry, with a decision date of February 23, 1977. It is regulated under CFR 862.1345 and is classified as substantially equivalent to a predicate device. The clearance indicates that it meets the regulatory standards for use in clinical settings as described in the provided data.
Can this assay be used for measuring glucose in fluids other than blood?
Yes, the Glucose (Hexokinase) Delta Test Assay is intended for quantifying glucose levels not only in blood but also in other body fluids. This versatility allows clinicians to assess glucose metabolism across various samples, supporting broader diagnostic evaluations for metabolic disorders and related conditions.